Dimitrios Iliopoulos is a scientist, inventor, and biotechnology executive with expertise in artificial intelligence (AI) and drug discovery and development. He is the co-founder and CEO of Athos Therapeutics Inc., a biotech company developing precision therapeutics for autoimmune and metabolic diseases, and co-founder of Chiron AI Labs, an agentic AI software company that helps researchers analyze complex datasets across the pharmaceutical, agricultural, and food industries. He is also a co-founder of Dyania Health Inc., an AI software company that automates and accelerates patient identification for complex clinical trials. In addition, he serves as Vice President of the Institute for the Advancement of Research and Education in Arts, Sciences, and Technology (ARISTEiA).

Dimitrios began his academic career as an Assistant Professor of Microbiology and Immunology at Harvard Medical School. He subsequently served as a tenured Associate Professor of Medicine at UCLA School of Medicine, where he founded and directed the UCLA Center for Systems Biomedicine with support from the Eli & Edythe Broad Foundation. He holds an MBA and a certificate in Finance from UCLA Anderson Business School.